EGFR and glioblastoma: The reasons for this were likely twofold, first these CARs only targeted this single antigen, which, while selective for GBM, was not as frequently upregulated as other antigenic targets discussed in this review, and second, EGFR-wild type remains the most frequently upregulated variant of EGFR in these tumours.